Literature DB >> 7160042

Tamoxifen (Nolvadex) therapy--radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer.

P M Wilkinson, G G Ribiero, H K Adam, J V Kemp, J S Patterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7160042     DOI： 10.1007/bf00257234

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  9 in total

1.  Measurement of tamoxifen in serum by thin-layer densitometry.

Authors:  H K Adam; M A Gay; R H Moore
Journal:  J Endocrinol       Date:  1980-01       Impact factor: 4.286

2.  Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

Authors:  D C Tormey; R M Simon; M E Lippman; J M Bull; C E Myers
Journal:  Cancer Treat Rep       Date:  1976-10

3.  Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer.

Authors:  P Wilkinson; G Ribeiro; H Adam; J Patterson
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data.

Authors:  C Fabian; L Sternson; M El-Serafi; L Cain; E Hearne
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

5.  Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites.

Authors:  A E Wakeling; S R Slater
Journal:  Cancer Treat Rep       Date:  1980 Jun-Jul

6.  Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.

Authors:  J S Patterson; R S Settatree; H K Adam; J V Kemp
Journal:  Eur J Cancer       Date:  1980       Impact factor: 9.162

7.  Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer.

Authors:  C Fabian; L Tilzer; L Sternson
Journal:  Biopharm Drug Dispos       Date:  1981 Oct-Dec       Impact factor: 1.627

8.  Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.

Authors:  C Fabian; L Sternson; M Barnett
Journal:  Cancer Treat Rep       Date:  1980 Jun-Jul

9.  Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers.

Authors:  H K Adam; J S Patterson; J V Kemp
Journal:  Cancer Treat Rep       Date:  1980 Jun-Jul
  9 in total
  3 in total

Review 1.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

2.  Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.

Authors:  R J Osborne; S T Malik; M L Slevin; V J Harvey; J Spona; H Salzer; C J Williams
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

3.  Tamoxifen metabolism: pharmacokinetic and in vitro study.

Authors:  M C Etienne; G Milano; J L Fischel; M Frenay; E François; J L Formento; J Gioanni; M Namer
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.